News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
VIKING GLOBAL INVESTORS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 5.1% stake in Five9, Inc. |
| 08/24/2023 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 6% stake in Valvoline Inc. |
| 06/05/2023 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 7.9% stake in Verastem, Inc. |
| 11/02/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 19.8% stake in Frazier Lifesciences Acquisitions Corporation |
| 10/07/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 10% stake in Trevi Therapeutics, Inc. |
| 07/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/20/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/14/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 9.5% stake in Standard BioTools Inc. |
| 02/14/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 12.8% stake in Roivant Sciences Ltd. |
| 01/21/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 12.4% stake in Amylyx Pharmaceuticals, Inc. |
| 01/18/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 5% stake in Guardant Health, Inc. |
| 10/15/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 4.6% stake in TDCX Inc. |
| 09/27/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 11.3% stake in PROCEPT BioRobotics Corporation |
| 08/09/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 13.1% stake in Rallybio Corporation |
| 07/19/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 5.2% stake in COUPA SOFTWARE INCORPORATED |
| 06/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/17/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 8.2% stake in Talaris Therapeutics, Inc. |
| 04/16/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 9.6% stake in MUDRICK CAPITAL ACQUISITION CORPORATION II |
| 04/05/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 7% stake in Edgewise Therapeutics, Inc. |
| 03/12/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 8.7% stake in Orion Acquisition Corp. |
| 02/12/2021 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 7.6% stake in Pharvaris N.V. |
| 12/21/2020 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 7.2% stake in AbCellera Biologics Inc. |
| 12/21/2020 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 14.9% stake in 4D Molecular Therapeutics, Inc. |
| 10/05/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/28/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/31/2020 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 13.6% stake in Inhibrx, Inc. |
| 08/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/27/2020 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 5.4% stake in GoHealth, Inc. |
| 03/10/2020 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 6.3% stake in Change Healthcare Inc. |
| 02/11/2020 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 30.9% stake in Adaptive Biotechnologies Corporation |
| 12/12/2019 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 6.8% stake in Chewy, Inc. |
|
|
|